• Otto欧图亮相2021亿邦跨境电商大会,共讨跨境电商新风口 2021-10-18
  • Oriental capital of museums Luoyang the magnificent 2021-10-18
  • 5686亩土地上新!成都第二批“双集中”供应地块将于9月15日开拍 2021-10-17
  • 56.8%受访青少年想投身航天事业 47.2%受访青少年长大想当航天员 2021-10-17
  • 2022国考今起报名 近七成招录计划专招应届生 2021-10-17
  • 2020年深圳“年度教师”揭晓 2021-10-16
  •  “特色小镇”:回归理性发展 2021-10-16
  • World Insights U.S. 20th 911 commemoration highlights need to reflect on war on terror 2021-09-23
  • World Insights Experts say Iran 2021-09-23
  • T3候机楼边,发现家性价比不错的自助餐厅 2021-09-23
  • SYPWAI对2021年人工智能步伐的影响 2021-09-23
  • Jefe de OMS Cumbre China 2021-09-22
  • Funcionários do governo e especialistas pedem maior cooperao para reviver turismo global 2021-09-22
  • Funcionario del PRD panameo destaca rol del PCCh Spanish.xinhuanet.com 2021-09-22
  • CBA股东大会 提交两套方案 2021-09-21
  • Global EditionASIA 中文双语Fran?ais
    Home / China / Health

    Clinical efficacy proof key for TCM advancement

    By Wang Xiaoyu | www.gospeljazzbyhlsteins.com | Updated: 2021-09-26 14:12
    Share - WeChat
    A pharmacist weighs traditional Chinese medicine ingredients to make a decoction for preventing COVID-19 infection at Jiangning TCM Hospital in Nanjing, Jiangsu province, on July 28, 2021. [Photo by YANG BO/CHINA NEWS SERVICE]

    大发快3-首页 www.gospeljazzbyhlsteins.com Establishing a clinical assessment system tailor-made to traits of the traditional Chinese medicine and integrating it with international practices is the key to advancing TCM development, experts said on Saturday.

    Zhang Junhua, head of the Tianjin University of Traditional Chinese Medicine's evidence-based medicine center, said that high quality evidence of clinical efficacy is the bedrock for modernizing and industrializing the TCM field, as well as promoting these therapies around the globe.

    Zhang is also the newly-elected head of the World Federation of Chinese Medicine Societies' clinical efficacy evaluation committee. He said the committee will strive to set up and improve evaluation methods that fit the characteristics and demands of TCM and put them into practices.

    Zhang Boli, honorary president of the Tianjin University of Traditional Chinese Medicine and an academician of the Chinese Academy of Engineering, said there has been a lack of high-quality evidence to explain mechanisms of TCM treatment, and addressing this problem should be a major task of TCM modernization in the future.

    "It is important to take note of clinical features of TCM medicines and come up with assessment criteria in a scientific and targeted manner," he said.

    Zhang raised an example manifested during the COVID-19 epidemic. Drawing from frontline experiences in treating patients with TCM, Chinese experts had developed a core outcome set — a standardized set of outcomes that should be measured and reported in all clinical trials as a minimum requirement. The new outcome set includes the rate of mild patients becoming severe cases, which has now been adopted worldwide.

    Liu Baoyan, chairman of the World Federation of Acupuncture-Moxibustion societies, said that integrating international norms for clinical efficacy evaluation with TCM remains a tough nut to crack. He also suggested using digital technologies, such as big data and artificial intelligence to help solve the issue.

    Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
    License for publishing multimedia online 0108263

    Registration Number: 130349